WASHINGTON - Stock values plummeted in the companies behind the molecular imaging agent Combidex (ferumoxtran-10) following a negative FDA panel vote. That thumbs-down damaged Advanced Magnetics Inc.'s shares by two-thirds and halved Cytogen Corp.'s stock. (BioWorld Today)